News
-
-
PRESS RELEASE
Sandoz reaches agreement with Regeneron, resolving all patent litigation related to its US aflibercept biosimilar
Sandoz reaches agreement with Regeneron on patent litigation related to US aflibercept biosimilar, enabling launch of Enzeevu™ by end of 2026. Agreement strengthens Sandoz biosimilar portfolio and expands US market growth strategy -
-
REGULATED PRESS RELEASE
Half-year report 2025
-
REGULATED PRESS RELEASE
Solid results in H1 2025. Operating margin: 23.2% - Net margin: 16.4%
Interparfums reports solid financial results in H1 2025 with an operating margin of 23.2% and a net margin of 16.4%. Sales reached €447m, a 5.8% increase compared to H1 2024. Key acquisitions and strategic plans ahead -
-
-
-
PRESS RELEASE
RE Royalties Announces Non-Brokered Listed Issuer Financing Equity Offering
RE Royalties Ltd. announces non-brokered private placement offering to raise up to $3,400,000 in gross proceeds through the issuance of up to 10,625,000 units at a price of $0.32 per unit. The Offering aims to fund working capital and general corporate purposes -
PRESS RELEASE
Apex Critical Metals Corp. Announces Private Placement of Flow-Through Units to Raise Gross Proceeds of up to $1,600,000
Apex Critical Metals Corp. announces a non-brokered $1,600,000 private placement offering of 800,000 flow-through units to fund exploration expenses. Offering set to close on Sep 30, 2025
